VivoSeq
Other

Allergies

0

Pipeline Programs↗

0

Active Trials↗

4

Companies Involved↗

Allergies is an early-stage landscape with 0 programs across 4 companies. The most active players are Lundbeck, Teva, GSK.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Lundbeck logo

Lundbeck

0 programs

PreclinicalTeva logo

Teva

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalJohnson & Johnson Pharmaceutical Research & Development, L.L.C. logo

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed10 · 100%

Clinical Trials

Trial Activity

10 trials

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)
Completed·—·Phase 4·NCT00794495·122 enrolled
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)
Completed·—·Phase 4·NCT00794599·118 enrolled
Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)
Completed·—·Phase 4·NCT00794768·118 enrolled
Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)
Completed·—·Phase 4·NCT00783133·131 enrolled
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)
Completed·—·Phase 4·NCT00794846·124 enrolled
A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen
Completed·Lundbeck logoLundbeck·Phase 1·NCT05126316·30 enrolled
Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
Completed·Teva logoTeva·Phase 3·NCT01307319·715 enrolled
To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies
Completed·GSK logoGSK·Phase 2·NCT01788813·42 enrolled
Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)
Completed·—·Phase 4·NCT00794248·122 enrolled
A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies
Completed·Johnson & Johnson Pharmaceutical Research & Development, L.L.C. logoJohnson & Johnson Pharmaceutical Research & Development, L.L.C.·Phase 1·NCT01054352·182 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)